Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso A/S is establishing an office in the UK to support the growth plan and is hiring Michelle Woolley as Area Sales Manager.

Monsenso, a technology leader in mobile health (mHealth) solutions for mental health is opening an office in London; Monsenso UK Ltd. to strengthen and support the expansion of the business in the UK, the company has hired Michelle Woolley as Area Sales Manager.

Michelle comes to Monsenso with a strong experience in sales management and business development from both Medtech and the pharmaceutical industry from i.e. Pfizer, 3M Healthcare, Servier, and Icentia

Michelle has a Microbiology degree BSc (Hons) from University of Bristol.

Michelle Woolley starts November 9, 2020.

With the opening of an office in the UK and the hiring of Michelle, we continue Monsenso’s international expansion in line with our growth strategy. Michelle will be an important addition to the team and we look forward to welcoming her”, says CEO Thomas Lethenborg.

Click on the link to read the press release in Danish.

For additional information, please contact:

Bettina van Wylich-Muxoll
Marketing
Monsenso
+45 22 70 47 24
marketing@monsenso.com

Transforming healthcare with technology-enabled care

Transforming healthcare with technology-enabled care

Connected health or technology-enabled care (TEC) is the collective term used for telecare, telehealth, telemedicine, mHealth, digital health, and eHealth services. TEC is now seen as a fundamental part of the solution to solve many healthcare challenges.

TEC helps people self-manage their health and wellbeing, alert healthcare professionals in case of any changes in an individual’s condition and support medication adherence.

It also helps clinicians and care providers deliver more efficient and cost-effective care.

Digital technology is advancing exponentially, and its cost is becoming more affordable. The need for more cost-effective healthcare is rising. Now more than ever, healthcare authorities need to adopt new technologies to help meet this demand.

Key trends

An aging population

The population is increasing, and people are living longer. These two factors, in addition to a rise in chronic conditions, present new healthcare challenges.

In the United States, population projection reports that older adults currently make up about 15% of the population, and by the year 2060 is estimated to amount to 23.5%.

There are similar numbers reported for Europe, where the group of 65-year old or older make up 19% of the population and is predicted to amount to 29% of the total population by the year 2080.

Use of mobile devices is increasing amongst all age groups

A 2019 report conducted by Provision Living, a senior living community in the U.S.,  revealed that on average, Baby Boomers (born between 1946 and 1964) and millennials (born between 1981 and 1995) spend on average, five hours a day on their smartphones.

Smartphone adoption among Americans:

  • Aged 50 to 59 is 86%
  • Aged 60 to 69 is 81%
  • Aged 70+ is 62%

Other market drivers

The demand for apps and wearable devices is also being driven by an increased focus on personalised care. Large pharmaceutical companies are now using apps and wearables to gather valuable health-related patient data, support their research, and provide an holistic service to patients.

In 2014, the leading pharmaceutical companies had an increase of 63 % in unique apps compared to 2013. In just one year, the total number of downloads of pharmaceutical apps increased by 197% as shown in Figure 1. These apps deliver education and training, can titrate medication and monitor compliance.

Figure 1. The number of apps published by leading pharmaceutical companies, 2013 and 2014.

There has also been an increase in online patient communities, using social media as a platform to exchange experiences with patients and carers.

Increasing patient trust in health apps

There is strong evidence that patients are now more than ever concerned about self-care, and they are interested in boosting their health and wellbeing. In addition to this, health technology companies are working to improve the quality of apps, increase user confidence and trust, and launch informed decision-making in app selection for health professionals, patients and the public.

Agencies like the US Food and Drug Administration (FDA), or NHS Choices and its NHS Health Apps Library have developed criteria that judge apps for safety and technical proficiency. For example, for apps to be included on the NHS Choices search website, which in early 2015 lists around 150 apps, they must be reviewed by a technical team (testing relevance, legal compliance and data protection), then by a clinical team (to test scientific rigour).

PatientView is an independent organisation that has developed a systematic method of appraising health apps. Until April 2015, there were 363 apps recommended for the Apple platform and 236 for Android, with smaller numbers recommended for use on other platforms.

In 2014, PatientView undertook a survey of 1,130 patient group members to identify what people want from health apps as shown in Figure 2.

Figure 2. What do patients and carers want from health apps?

References:

Connected Health: How Digital technology is transforming health and social care. Deloitte Health.

Forget Generational Stereotypes, Baby Boomers Are Just As Addicted To Smart Phones As Millennials. 

Older Adults Keep Pace on Tech Usage.

An Aging Population, Larger Chronic Disease Burden, and Reliance on Digital Self-Management Tools Require Contributions from Nurse Informaticians.

What Is the difference between a health app and an mhealth solution?

What Is the difference between a health app and an mhealth solution?

Over the past few years, mHealth solutions have begun to solve some of the problems that are ailing healthcare. MHealth is paving the way for better data management, doctor-patient communication, reduced hospital admissionsmedication adherence, and remote patient monitoring. 

MHealth solutions are improving outcomes in measurable, repeatable ways by connecting patients with their doctors.

In 2017 mHealth captured $23 billion in revenues, with an estimated growth rate of 35% annually over the next several years.

What is the difference between a health app and an mHealth solution?

Health apps are application programmes that offer health-related services for smartphones, tablets, PCs, and other communication devices.

The most popular categories of health/wellness apps are: 

  • Sports and fitness activity tracking
  • Diet and nutrition
  • Weight loss coaching
  • Medication tracking
  • Sleep cycle
  • Stress and relaxation
  • Meditation
  • Menstrual period tracking
  • Pregnancy
  • Hospital selection and appointment tracking

Health apps can provide valuable information to users. However, it may be hard to determine the accuracy of the information provided and may not be easy to share this data with the user’s doctor.

MHealth or mobile health refers to the practice of medicine and public health supported by mobile devices such as mobile phones, tablets, personal digital assistants and wireless infrastructure. It encompasses all applications of telecommunications and multimedia technologies for the delivery of healthcare and health information.

Why is mHealth used?

  • Provides education and awareness
  • Assists with diagnostic and treatment support
  • Enables remote data collection
  • Facilitates remote monitoring
  • Enables telemedicine
  • Supports chronic disease management
  • Support medication compliance

Numerous mHealth initiatives across the world have demonstrated the efficacy of using mobile devices to deliver better care in a cost-effective manner.

Many mHealth solutions offer different types of information sharing, such as data collection through patient self-assessments, electronic questionnaires, and sensor data. They can also offer emergency action plans and an encrypted messaging system that allows direct communication with the clinic.

Besides, many mHealth solutions are considered certified medical devices that have a proven record of helping healthcare professionals in the monitoring and treatment of their patients.

Both, health apps and mHealth solutions can both be used on-the-go. However, the main difference is that health apps are for consumers-only and mHealth solutions improve the collaboration between patients and healthcare professionals.

References:

mHealth (Mobile Healthcare) Ecosystem Market: 2017-2030 – $23 Billion Opportunities, Challenges, Strategies & Forecasts.

Health apps definition.

What is mHealth?

 

Big Data in treating mental disorders

Big Data in treating mental disorders

Big data in treating mental disorders explains how data is transforming the treatment of mental disorders and the overall life science industry. Monsenso’s mHealth solution shows how technology provides new ways to inform treatment and achieve scalability. This is a blog post written by Mads Frost PhD, Co-founder and Chief Product Officer of Monsenso

The challenge with mental health today

According to numerous analyses and forecasts conducted by several international organizations and authorities, mental health today is one of the biggest challenges for society and health budgets. In fact, the World Health Organization (WHO) has predicted that mental disorders will be the greatest health burden for society in the coming years. This emphasizes the need for solutions to remedy this. Presently, technology is the best bet.

An example of the utilisation of technology to help overcome the burden of mental health for society is Monsenso. Monsenso is an innovation leader in mHealth solutions for the treatment of mental disorders. Monsenso helps support the treatment of mental disorders by inspiring and strengthening cooperation between patients and therapists.

Based on continuous research with leading experts in psychiatry, pervasive healthcare and data science, Monsenso has designed an innovative solution that fits into each patient’s life and helps them to better manage their disease as well as increasing the quality and effectiveness of treatment. It has been developed in a user-centred design approach, with patients, clinicians and relatives, to ensure that the solution is easy to apply and fits into the patient’s life and treatment.

The mental x-ray

Through daily self-assessment, clinical questionnaires, and collection of behavioural data from both sensors in modern Smartphone, wearables, and even voice analyses of patients’ voices, Monsenso provides the patient and the therapist with a detailed insight into the user’s mental health state. Through the application of advanced data analysis, indicators such as behavioural patterns, contexts and even forecasting future conditions and risk levels can be demonstrated – all with the purpose of gaining better insight into the patient’s mental health and providing an improved basis for treatment.

Generally, many organizations are fighting to realize mHealth’s full potential. According to a study where clinicians have been asked: “What is your most pressing information technology problem”, the answer that received the highest percentage of responses was, “turning data into action.” [1]

Psychiatry has previously used paper schemes to collect information from patients. However, but current technology provides access to a wide range of information that has not previously been available. This technology can be called the mental x-ray, in that using this technology can be used to see and monitor mental functioning with x-ray like precision and detail. This allows for early interventions and to help patients when they are in need. An example of this at work is the Monsenso based research into using voice analysis as an objective state marker for bipolar disorder . [2]

Paradigm shift in treatment: How do we achieve scalability?

To achieve the benefits of technology, it is necessary to adapt the clinical workflows. Psychiatry has a very traditional form of treatment where the patient meets the therapist and receives face-to-face treatment. The future brings more patients and fewer therapists – how do we scale this?

One possible solution is to optimising treatment is to use monitoring systems. These systems can rapidly identify which patients are in need of help, and which ones are well. In this way, clinicians’ time can be focused on patients who are in need.  Likewise, the systems can be more treatment-supporting, taking over the trivial and automatable tasks of the clinician, allowing them to spend their time on those with the greatest needs – the complex cases that technology cannot help. The last perspective – a paradigm shift in treatment – is to go from a reactive to a proactive approach. The proactive approach comes from gathering more detailed information, to lead to more informed decisions and earlier interventions. More information can help immediately notify both patients and clinicians when things start to go in the wrong direction, and need help to prevent potential hospitalisations. And the patients, who are well, can focus on life and not illness. However, it is important to keep in mind that it is not a trivial task to realise this.

How should we realise the potential of ‘Big Data’

On an overall level, there are a number of points that companies that are active in data-driven health technology should think about to thrive in complex health environments:

  • Find applications and services that bring tangible value to identifiable stakeholders – it must provide meaning and value to end users
  • Think on a global scale
  • Focus on solutions, not technology
  • Identify potential partners to create greater impact and find new value

Most of all, those who come from the outside into the healthcare domain must avoid the trap of seeing technology as something different from healthcare. Its greatest value will be how it integrates with healthcare systems and allows clinicians to provide better care for patients.

In some cases, technology will appear illusory: Personal contact between patient and therapist will always have a place in treatment, but data driven approaches can revolutionise the basis on which treatment is given.

Where are we going?

There are many possibilities that presents itself when exploring data driven approaches. I have  particularly emphasised ‘Context Aware Computing’ as one of the perspectives that are important to pursue. The goal is to use the context of the patients to provide the right intervention, to the right patient, at the right time, at the right place. This is not a trivial task, but extremely important for solutions like Monsenso to really help patients. The present systems are still relatively unintelligent in terms of achieving this, based on the amount of data available. It is difficult to know the context of what the collected data in the system is based on – what experiences and thoughts the patients have.

[1]  Top 5 industry challenges of 2016 By Aubrey Westgate, November 30, 2015  http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/top-5-industry-challenges-2016?page=0,0

[2]  VOICE ANALYSIS AS AN OBJECTIVE STATE MARKER IN BIPOLAR DISORDER. M Faurholt-Jepsen, J Busk, M Frost, M Vinberg, EM Christensen, O Winther, JE Bardram, and LV Kessing. Translational Psychiatry, 2016. (ISSN: 2158-3188) (DOI: http://dx.doi.org/10.1038/ tp.2016.123), vol: 6, issue: 7, 2016

Can mHealth technology be used to save costs ?

Can mHealth technology be used to save costs ?

According to an article published on Harvard Business Review, digital health tools have the potential to provide effective, low-cost ways to prevent and treat chronic illnesses. The article states that these technology-based solutions that have a clinical impact on disease are comparable to the effectiveness of a drug, and they use consumer-grade technology such as mobile devices and big data analytics that can be deployed in real-time and at scale, which is critical for the management of chronic diseases.

From the chronic diseases, mental illnesses account for five of the ten leading causes of disability worldwide [1]. Therefore, prevention as well as the the early identification and treatment of mental illness represents a high priority since it promotes recovery, independence, self-sufficiency, as well as facilitating social activities and employment opportunities [2].

In fact, in the UK alone, depression and anxiety accounted for 11.7 million lost working days last year [3].  Moreover, according to the American Medical Association, stress accounts for 60% of all human illness and disease [4], which means that clinically-tested health apps can help government authorities, corporations and insurance companies reduce their costs by monitoring individuals remotely and intervening at an early stage.

Nowadays, the majority of large employers that offer health benefits also offer a wellness programme in an effort to promote employee health and productivity as well as to reduce health-related costs.

We live in an era where certified and clinically-tested health apps, or mobile health solutions (as they are widely known), are readily available, or are being developed for most chronic diseases.

Most of these digital tools are extremely easy to use, and can be obtained by downloading an application from iOS or Google Play, signing-up, and sharing your information with a coach. The clear advantages of this technology are scalability and low-cost, since an effective health app bundled up with a telehealth can provide affordable support to either 50 or 5 million users.

The Monsenso mHealth solution can be used by insurance companies and large corporations to reduce costs by offering a preventive mental wellness programme. Individuals can use the Monsenso smartphone app to enter their daily levels of stress, anxiety, irritability, physical activity and number of hours they slept. This information is gathered and stored electronically so it can be accessed by a healthcare professional anytime, anywhere. However, the coach only needs to take action when the web portal indicates that certain individuals present any triggers or warning signs. For example, the coach will be notified when anyone in the system indicates a high level of stress, anxiety and irritability for more than five consecutive days or when someone sleeps less than six hours for more than three consecutive days. These two actions would be considered indicators that the individual needs to be contacted for a “wellness check” and implement the necessary measures to prevent the person from going on stress-leave or from becoming affected by other physical conditions such as heart disease.

References:

[1] Prevention of Mental Disorders. Effective Interventions and policy options. World Health Organisation in collaboration with the Prevention Research Centre of the Universities of Nimegen and Maastricht. http://www.who.int/mental_health/evidence/en/prevention_of_mental_disorders_sr.pdf

[2] Early intervention and recovery for young people with early psychosis: consensus statement. J. Bertolote and P. McGorry. British Journal of Psychiatry (2005). http://bjp.rcpsych.org/content/bjprcpsych/187/48/s116.full.pdf

[3] Stress in the City: ‘At first, I thought my depression was a heart attack’. The Telegraph. Peter Stanford. (2017, January 7)
http://www.telegraph.co.uk/men/health/stress-city-first-thought-depression-heart-attack/

[4] How Stress Affects the Body (INFOGRAPHIC). Huffington Post. (2013, January 10)
http://www.huffingtonpost.com/heartmath-llc/how-stress-affects-the-body_b_2422522.html

Simple Digital Technologies Can Reduce Health Care Costs.
Harvard Business Review. Alexander L. Fogel, Joseph C. Kvedar. (2016, November 14).
https://hbr.org/2016/11/simple-digital-technologies-can-reduce-health-care-costs